Evidence map›Paper›PMID 42131770›Full record

ArticleJournal of inflammation research2026

A Cohort Study on Systemic Immune-Inflammation Index and Its Longitudinal Change in Relation to Colorectal Adenoma Recurrence.

Yujie Sun, Jingfeng Chen, Jiaoyan Li, Jianan Shao, Weikang Li, Suying Ding

Abstract read
In one paragraph

Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yujie Sun *Health Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.
Jingfeng Chen *Health Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.ORCID 0009-0005-2898-1490
Jiaoyan LiMedical Affairs Department, Gaoping People's Hospital, Jincheng, Shanxi, 048400, People's Republic of China.ORCID 0009-0004-1118-5239
Jianan ShaoHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.
Weikang LiHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.
Suying DingHealth Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.ORCID 0000-0002-2649-8332

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to investigate the associations of both baseline systemic immune-inflammation index (SII) and, more importantly, its longitudinal change (ΔSII) during follow-up with the risk of advanced colorectal neoplasia (ACRN) recurrence after endoscopic resection of colorectal adenomas. Methods: Clinical data from 1855 patients diagnosed with colorectal adenomas and undergoing resection at Hospital between January 2017 and August 2023 were analyzed. Patients were classified into Q1-Q4 groups based on baseline SII quartiles and into three groups according to ΔSII. Cox proportional hazards regression models, restricted cubic spline (RCS) analysis, Kaplan-Meier curves, receiver operating characteristic (ROC) curve, subgroup analysis, sensitivity analyses were used to evaluate associations. Results: After an average follow-up of 3.4 years, 166 patients (8.95%) experienced ACRN recurrence. After fully adjusting for variables, Cox proportional hazards regression analysis revealed that the group with the highest baseline SII (Q4) had a 1.75-fold increased risk of ACRN recurrence compared to Q1 (HR, 1.75; 95% Conclusion: Not only baseline SII but also ΔSII during follow-up serves as a significant and independent predictor for ACRN recurrence. Monitoring the longitudinal change of SII may provide incremental clinical value for optimizing personalized surveillance strategies after endoscopic resection.

Indexed as

advanced colorectal neoplasiacohort studycolorectal cancerrecurrencesystemic immune-inflammation index

Identifiers

PMID42131770
PMCPMC13165470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.